INSM vs GILD: Which Stock is Better?
Side-by-side comparison of Insmed Inc and Gilead Sciences Inc in 2026
INSM
Insmed Inc
$146.74
GILD
Gilead Sciences Inc
$139.77
Key Metrics Comparison
| Metric | INSM | GILD | Winner |
|---|---|---|---|
| Market Cap | $31.67B | $174.33B | GILD |
| P/E Ratio | N/A | 20.72 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 1.5% | 0.0% | INSM |
| Gross Margin | 79.7% | 78.8% | INSM |
Analyze INSM
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INSM or GILD a better investment?
Comparing INSM and GILD: Insmed Inc has a market cap of $31.67B while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INSM and GILD?
INSM (Insmed Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INSM or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INSM or GILD?
INSM has higher revenue growth at 1.5% vs 0.0% for GILD.
Which company is more profitable: INSM or GILD?
Insmed Inc (INSM) has higher gross margins at 79.7% compared to 78.8% for GILD.
Which is the larger company: INSM or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $31.67B for INSM.
Should I buy INSM or GILD in 2026?
Both INSM and GILD have investment merit. INSM trades at $146.74 while GILD trades at $139.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INSM and GILD stock?
Key differences: Market Cap ($31.67B vs $174.33B), P/E Ratio (N/A vs 20.7x), Revenue Growth (1.5% vs 0.0%), Gross Margin (79.7% vs 78.8%).